SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

IMS & AGM

18 Apr 2013 07:00

RNS Number : 6284C
Devro PLC
18 April 2013
 



For immediate release 18 April 2013

 

 

Devro plc

(the "Group")

 

Interim Management Statement and Annual General Meeting

Devro plc, one of the world's leading manufacturers of collagen products for the food industry, today issues the following Interim Management Statement for the period from 1 January 2013 to date, ahead of its Annual General Meeting to be held at 11.00am. Steve Hannam, Chairman of Devro, will make the following statement on current trading.

 

"Devro's global sales have continued to grow during the period. This has been underpinned by good growth in much of Europe and North America, offset by a slower start in the UK and Australia. Select has begun the year well, particularly in Germany where it continues to make good progress.

 

"The major capital investment programme in the Czech Republic is proceeding as planned, with significant additional volume scheduled to come on stream in the second half of this year in order to support further growth in 2014.

 

"As announced at the time of the 2012 preliminary results, we have now implemented the planned price increases we referred to at that time. Input costs have also risen broadly in line with our expectations.

 

"Manufacturing performance, however, has been held back by lower yields, particularly in the USA, which has restricted product available for sale and impacted unit costs.

 

"We remain confident that the Group will meet the board's expectations for the full year. Whilst profits for the first quarter of the year are below the corresponding period in 2012 due to lower production yields, remedial action has already been taken and, with the benefits of recent price rises, additional volume from extra capacity and a focus on improving production processes, we do expect stronger performance as the year progresses.

 

"Net debt and cash flow are both as expected and the financial position of Devro continues to be strong."

 

Peter Page, Chief Executive, commented "Sales continue to grow in volume and value terms across the Group and our investments in people and infrastructure will ensure we have the necessary capability to take advantage of the significant opportunities that exist."

 

ENDS

 

For further information, please contact:

 

Devro plc

Peter Page, Chief Executive

Simon Webb, Group Finance Director

 

 

 

Tel No: 0207 182 4960

 

Buchanan

Diane Stewart/ Carrie Clement/

Charles Ryland

 

 

 

Tel No: 020 7466 5000/0131 226 6150

www.buchanan.uk.com

 

Notes to Editors

 

FTSE 250 listed Devro is one of the world's leading providers of collagen casings to the food industry supplying a wide range of products and technical support to manufacturers of sausages, salamis, hams and other cooked meats. The Group employs 2,200 staff across the world and produces its casings from 5 manufacturing sites based in Scotland, Australia, the Czech Republic and the USA. Devro reported sales of £241.1 million and profit before tax (excluding pension interest) of £42.2 million for the year ended 31 December 2012. Devro is a constituent of the FTSE4Good Index Series which recognises that the company's performance meets globally recognised corporate responsibility standards.

 

Further information on Devro can be found on the company's website: www.devro.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGUWUCUPWGBM
Date   Source Headline
13th Sep 20183:23 pmRNSHolding(s) in Company
3rd Sep 20184:44 pmRNSHolding(s) in Company
9th Aug 20181:48 pmRNSDirector/PDMR Shareholding
9th Aug 20181:45 pmRNSDirector/PDMR Shareholding
1st Aug 20184:55 pmRNSHolding(s) in Company
1st Aug 20187:00 amRNSHalf Year Results
9th Jul 20184:30 pmRNSHolding(s) in Company
4th Jul 20183:58 pmRNSHolding(s) in Company
4th Jun 20183:19 pmRNSHolding(s) in Company
16th May 20182:47 pmRNSHolding(s) in Company
15th May 20183:11 pmRNSDirector/PDMR Shareholding
14th May 20184:46 pmRNSDirector/PDMR Shareholding
8th May 20182:30 pmRNSHolding(s) in Company
4th May 201810:41 amRNSHolding(s) in Company
30th Apr 20183:28 pmRNSDirector/PDMR Shareholding
25th Apr 20184:49 pmRNSAGM - VOTING RESULTS
25th Apr 20187:00 amRNSTrading Update
19th Apr 20183:38 pmRNSHolding(s) in Company
10th Apr 201811:11 amRNSDirector/PDMR Shareholding
9th Apr 20184:00 pmRNSDirector/PDMR Shareholding
3rd Apr 20187:06 amRNSDirector Declaration
29th Mar 20181:00 pmRNSAppointment of Chief Financial Officer
23rd Mar 20184:00 pmRNS2017 Annual Report and Notice of AGM
28th Feb 201811:28 amRNSDirector/PDMR Shareholding
28th Feb 20187:00 amRNSDirectorate change confirmation
27th Feb 20187:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2017
7th Feb 20184:52 pmRNSHolding(s) in Company
12th Jan 20184:08 pmRNSHolding(s) in Company
5th Jan 20184:54 pmRNSHolding(s) in Company
19th Dec 20172:26 pmRNSHolding(s) in Company
19th Dec 20179:20 amRNSHolding(s) in Company
18th Dec 20174:33 pmRNSHolding(s) in Company
11th Dec 20173:02 pmRNSDirector/PDMR Shareholding
11th Dec 20177:00 amRNSDirectorate Change
9th Nov 20177:00 amRNSTrading Update
26th Oct 201712:20 pmRNSDirector/PDMR Shareholding
18th Aug 20174:18 pmRNSHolding(s) in Company
17th Aug 20175:03 pmRNSHolding(s) in Company
8th Aug 201710:35 amRNSHolding(s) in Company
2nd Aug 20174:54 pmRNSDirector/PDMR Shareholding
2nd Aug 20174:46 pmRNSDirector/PDMR Shareholding
2nd Aug 20174:45 pmRNSDirector/PDMR Shareholding
2nd Aug 20177:00 amRNSDevro plc Half Year Results 2017
23rd Jun 201710:03 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
30th May 201711:01 amRNSBlock Listing Six Monthly Return
16th May 20172:38 pmRNSHolding(s) in Company
26th Apr 20175:15 pmRNSResult of AGM
26th Apr 20177:00 amRNSTrading Update
20th Apr 20178:32 amRNSHolding(s) in Company
11th Apr 20174:12 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.